Masimo and Qualcomm join forces to develop advanced smartwatch platform for Wear OS

Pallavi Madhiraju- September 15, 2024 0

Masimo (NASDAQ: MASI), a global leader in medical technology, has announced a partnership with Qualcomm Technologies, Inc. to develop a next-generation smartwatch reference platform for ... Read More

MightySat Medical : Masimo introduces first FDA-cleared OTC medical fingertip pulse oximeter

Pallavi Madhiraju- February 15, 2024 0

Masimo (NASDAQ: MASI) has made an advancement in consumer health technology with the announcement of US Food and Drug Administration (FDA) clearance for MightySat Medical. ... Read More

Masimo W1 medical watch receives FDA 510(k) clearance for OTC and prescription use

Pallavi Madhiraju- November 19, 2023 0

Masimo (NASDAQ: MASI) has announced the FDA 510(k) clearance of the Masimo W1 medical watch for both over-the-counter (OTC) and prescription use. This groundbreaking approval ... Read More

Masimo gets FDA clearance for Centroid patient monitoring sensor

pharmanewsdaily- June 28, 2020 0

Masimo, a US medical device company, has received clearance from the US Food and Drug Administration (FDA) for Centroid, the company's wearable, wireless patient orientation, ... Read More